450 related articles for article (PubMed ID: 19283656)
1. Neonate exposure to thimerosal mercury from hepatitis B vaccines.
Dórea JG; Marques RC; Brandão KG
Am J Perinatol; 2009 Aug; 26(7):523-7. PubMed ID: 19283656
[TBL] [Abstract][Full Text] [Related]
2. Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content.
Chang S; Begier EM; Schech SD; Venus P; Shatin D; Braun MM; Ball R
Pediatr Infect Dis J; 2007 Apr; 26(4):329-33. PubMed ID: 17414397
[TBL] [Abstract][Full Text] [Related]
3. Time of perinatal immunization, thimerosal exposure and neurodevelopment at 6 months in breastfed infants.
Marques RC; Dórea JG; Manzatto AG; Bastos WR; Bernardi JV; Malm O
Acta Paediatr; 2007 Jun; 96(6):864-8. PubMed ID: 17465985
[TBL] [Abstract][Full Text] [Related]
4. Iatrogenic exposure to mercury after hepatitis B vaccination in preterm infants.
Stajich GV; Lopez GP; Harry SW; Sexson WR
J Pediatr; 2000 May; 136(5):679-81. PubMed ID: 10802503
[TBL] [Abstract][Full Text] [Related]
5. Early mercury exposure (with ethylmercury) could include 3-day olds: is that the case in China?
Dórea JG
Environ Res; 2008 Mar; 106(3):420; discussion 421-2. PubMed ID: 18221937
[No Abstract] [Full Text] [Related]
6. Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines.
Pichichero ME; Gentile A; Giglio N; Umido V; Clarkson T; Cernichiari E; Zareba G; Gotelli C; Gotelli M; Yan L; Treanor J
Pediatrics; 2008 Feb; 121(2):e208-14. PubMed ID: 18245396
[TBL] [Abstract][Full Text] [Related]
7. Impact of the 1999 AAP/USPHS joint statement on thimerosal in vaccines on infant hepatitis B vaccination practices.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2001 Feb; 50(6):94-7. PubMed ID: 11263794
[TBL] [Abstract][Full Text] [Related]
8. Effect of thimerosal recommendations on hospitals' neonatal hepatitis B vaccination policies.
Brayden RM; Pearson KA; Jones JS; Renfrew BL; Berman S
J Pediatr; 2001 May; 138(5):752-5. PubMed ID: 11343056
[TBL] [Abstract][Full Text] [Related]
9. The evidence for the safety of thiomersal in newborn and infant vaccines.
Clements CJ
Vaccine; 2004 May; 22(15-16):1854-61. PubMed ID: 15121295
[TBL] [Abstract][Full Text] [Related]
10. Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink.
Young HA; Geier DA; Geier MR
J Neurol Sci; 2008 Aug; 271(1-2):110-8. PubMed ID: 18482737
[TBL] [Abstract][Full Text] [Related]
11. Principal component analysis and discrimination of variables associated with pre- and post-natal exposure to mercury.
Marques RC; Bernardi JV; Dórea JG; Bastos WR; Malm O
Int J Hyg Environ Health; 2008 Oct; 211(5-6):606-14. PubMed ID: 18160342
[TBL] [Abstract][Full Text] [Related]
12. Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism.
Price CS; Thompson WW; Goodson B; Weintraub ES; Croen LA; Hinrichsen VL; Marcy M; Robertson A; Eriksen E; Lewis E; Bernal P; Shay D; Davis RL; DeStefano F
Pediatrics; 2010 Oct; 126(4):656-64. PubMed ID: 20837594
[TBL] [Abstract][Full Text] [Related]
13. Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United kingdom does not support a causal association.
Andrews N; Miller E; Grant A; Stowe J; Osborne V; Taylor B
Pediatrics; 2004 Sep; 114(3):584-91. PubMed ID: 15342825
[TBL] [Abstract][Full Text] [Related]
14. Thimerosal exposure in infants and developmental disorders: a prospective cohort study in the United kingdom does not support a causal association.
Heron J; Golding J;
Pediatrics; 2004 Sep; 114(3):577-83. PubMed ID: 15342824
[TBL] [Abstract][Full Text] [Related]
15. Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases.
Verstraeten T; Davis RL; DeStefano F; Lieu TA; Rhodes PH; Black SB; Shinefield H; Chen RT;
Pediatrics; 2003 Nov; 112(5):1039-48. PubMed ID: 14595043
[TBL] [Abstract][Full Text] [Related]
16. Neuropsychological performance 10 years after immunization in infancy with thimerosal-containing vaccines.
Tozzi AE; Bisiacchi P; Tarantino V; De Mei B; D'Elia L; Chiarotti F; Salmaso S
Pediatrics; 2009 Feb; 123(2):475-82. PubMed ID: 19171612
[TBL] [Abstract][Full Text] [Related]
17. [Lack of association between thimerosal-containing vaccines and autism].
Mrozek-Budzyn D; Majewska R; Kiełtyka A; Augustyniak M
Przegl Epidemiol; 2011; 65(3):491-5. PubMed ID: 22184954
[TBL] [Abstract][Full Text] [Related]
18. Exposure to thimerosal in vaccines used in Canadian infant immunization programs, with respect to risk of neurodevelopmental disorders.
Bigham M; Copes R; Srour L
Can Commun Dis Rep; 2002 May; 28(9):69-80. PubMed ID: 12012653
[No Abstract] [Full Text] [Related]
19. Low-dose mercury exposure in early life: relevance of thimerosal to fetuses, newborns and infants.
Dórea JG
Curr Med Chem; 2013; 20(32):4060-9. PubMed ID: 23992327
[TBL] [Abstract][Full Text] [Related]
20. [Mercury in vaccines].
Hessel L
Bull Acad Natl Med; 2003; 187(8):1501-10. PubMed ID: 15146581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
